Genome-wide Mendelian randomization study identifies therapeutic targets for diabetic microangiopathy.
- DOI
- 10.1016/j.diabres.2025.112237
- Published
- 2025 Jul
- Container
- Diabetes research and clinical practice
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.diabres.2025.112237,
title = {Genome-wide Mendelian randomization study identifies therapeutic targets for diabetic microangiopathy.},
author = {Yang X and Liu Q and Ma Q and Fan X and Huang C and Zhao Y and Xia J and Liu T and Zhou H and Yan B},
year = {2025},
journal = {Diabetes research and clinical practice},
doi = {10.1016/j.diabres.2025.112237},
url = {https://doi.org/10.1016/j.diabres.2025.112237}
}RIS
TY - JOUR TI - Genome-wide Mendelian randomization study identifies therapeutic targets for diabetic microangiopathy. AU - Yang X AU - Liu Q AU - Ma Q AU - Fan X AU - Huang C AU - Zhao Y AU - Xia J AU - Liu T AU - Zhou H AU - Yan B PY - 2025 JO - Diabetes research and clinical practice DO - 10.1016/j.diabres.2025.112237 UR - https://doi.org/10.1016/j.diabres.2025.112237 ER -
APA
X, Y., Q, L., Q, M., X, F., C, H., Y, Z., J, X., T, L., H, Z., & B, Y. (2025). Genome-wide Mendelian randomization study identifies therapeutic targets for diabetic microangiopathy.. Diabetes research and clinical practice. https://doi.org/10.1016/j.diabres.2025.112237
Source records
- pubmed · retrieved 2026-09-25T15:16:15.850Z